10 results
·
19ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
TPN FLUID TRANSFER SET
FDA 510(k)
FDA Class 2
·General Hospital
FLI Twin
FDA UDI
Rmo, Inc.·00885797562463·FLI(R) TWIN BIO .018 WITH HOOK ON CUSPID 5-5 20...
FLOCARE N
FDA 510(k)
FDA Class 1
·Anesthesiology
TROJAN RIBBED LATEX CONDOMS W/SPERM. MODIFIED
FDA 510(k)
FDA Class 2
·Obstetrics/Gynecology
CTA HUMERAL HEADS (COCRMO) DIA.54MM
FDA Adverse Event
Injury
·LIMACORPORATE S.P.A.·Product code HSD·June 24, 2020
TRILOGY 100
FDA Adverse Event
Malfunction
·RESPIRONICS, INC.·Product code CBK·May 28, 2014
XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM
FDA Adverse Event
Malfunction
·AV-TEMECULA-CT·Product code NIQ·January 9, 2013
SWAN-GANZ TRUE SIZE MONITORING CATHETER DOUBLE LUMEN
FDA Adverse Event
Malfunction
·EDWARDS LIFESCIENCES, PR·Product code DQO·November 22, 2010
Assurity Model Numbers: PM1240, PM2240; Assurity + Model Number: PM2260; Accent Model Numbers: PM1210, PM2210, PM1222, PM2212; Accent MRI Model Numbers: PM1224, PM2218, PM2224 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017
Allura Exper FD Series. System codes 722003 722010 722022 722005 722011 722019 722001 722002 722006 722012 722008 722013 722020 722025 722015 722023 722038 889006 889016 889009 722005 The device is an X-Ray Generator.
FDA Enforcement
Class II
·Terminated·Philips North America, LLC·March 25, 2020